Tang Cong, Offermanns Stefan
Novartis Institutes for Biomedical Research, Basel, Switzerland.
Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstr. 43, 61231, Bad Nauheim, Germany.
Handb Exp Pharmacol. 2017;236:205-220. doi: 10.1007/164_2016_50.
The short-chain fatty acid receptors FFA2 (GPR43) and FFA3 (GPR41) are activated by acetate, propionate, and butyrate. These ligands are produced by bacteria in the gut. In addition, the body itself can in particular produce acetate, and acetate plasma levels have been shown to be increased, e.g., in diabetic patients or during periods of starvation. FFA2 and FFA3 are both expressed by enteroendocrine cells and pancreatic β-cells. In addition, FFA2 is found on immune cells and adipocytes, whereas FFA3 is expressed by some peripheral neurons. It has therefore been speculated that short-chain fatty acid receptors are involved in the regulation of various body functions under different nutritional and metabolic conditions. Here we summarize recent data on the role of FFA2 and FFA3 in the regulation of metabolic, immunological, and neuronal functions and discuss the potential pharmacological relevance of this receptor system.
短链脂肪酸受体FFA2(GPR43)和FFA3(GPR41)可被乙酸盐、丙酸盐和丁酸盐激活。这些配体由肠道细菌产生。此外,机体自身尤其能够产生乙酸盐,并且已表明乙酸盐的血浆水平会升高,例如在糖尿病患者中或饥饿期间。FFA2和FFA3均由肠内分泌细胞和胰腺β细胞表达。此外,FFA2存在于免疫细胞和脂肪细胞上,而FFA3由一些外周神经元表达。因此,有人推测短链脂肪酸受体在不同营养和代谢条件下参与多种身体功能的调节。在此,我们总结了关于FFA2和FFA3在代谢、免疫和神经功能调节中作用的最新数据,并讨论了该受体系统潜在的药理学相关性。
Handb Exp Pharmacol. 2017
Neurogastroenterol Motil. 2018-8-23
Mol Pharmacol. 2016-3
Handb Exp Pharmacol. 2017
Front Endocrinol (Lausanne). 2012-10-2
Eur J Pharmacol. 2021-9-5
Biochim Biophys Acta Mol Cell Biol Lipids. 2020-2-13
J Multidiscip Healthc. 2022-11-9
Front Cell Infect Microbiol. 2021
World J Gastroenterol. 2021-11-21
Metabolites. 2021-5-11